Anti-Cancer Drugs

The year 2016 witnessed recordable number of US Food and Drug Administration (FDA) approvals of new pharmaceuticals, including new molecular entities (NMEs) and new Biologic License Applications (BLAs). The number was as high as 45 NMEs and BLAs in all disease states compared with 41 approved in 2014 and only 27 in 2013. Out of these 45 NMEs and BLAs entering the market last year, 16 were novel therapies for cancer. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), as many as 836 drugs and vaccines are at various stages of development for cancer; these are either in clinical trials or are awaiting review by the FDA.


Of the 836 drugs and vaccines for cancer:


  • 123 are for lung cancer (still the leading cause of cancer-related death in the United States)
  • 106 for leukaemia
  • 92 for lymphoma (including non-Hodgkin lymphoma)
  • 82 for breast cancer (the leading cancer in US women)
  • 58 for brain tutors
  • 53 for skin cancer (including melanoma)

  • Alkylating Agents
  • Platinum Analogs
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Hormonal Agents
  • Differential Inducer
  • Gene Targeted Drugs
  • Immunomodulators
  • Antiangiogenesis Drugs

Related Conference of Anti-Cancer Drugs

April 20-21, 2018

4th International Conference on Antibiotics: R&D, B2B

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

15th Annual European Pharma Congress

Frankfurt, Germany
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
June 27-28, 2018

International Conference on Pharmaceutical Analysis and Quality Control Strategies

Vancouver, British Columbia, Canada
July 16-17, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 18-19, 2018

International Conference on Pharmaceutical Oncology

Atlanta, Georgia, USA
July 18-20, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
August 15-17, 2018

14th World Congress on Pharmacology and Drug Safety

Stockholm, Sweden
August 28-30, 2018

10th World Congress on Neuropharmacology

Paris, France
September 07-08, 2018

5th Annual Congress on Clinical Pharmacy & Pharmacology

Tokyo, Japan
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 14-15, 2018

Annual Neurochemistry and Neuropharmacology Congress

Richmond, Virginia, USA
September 17-18, 2018

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
September 17-18, 2018

11th World Congress on Pharmacology & Therapeutics

| San Antonio, Texas, USA
September 17-18, 2018

Gulf Congress on Pharmacy and Pharmaceutical Sciences

Abu Dhabi, UAE
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic
September 24-25, 2018

World Congress on Traditional and Complementary Medicine

Abu Dhabi, UAE
September 24-26, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 08-09, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Frankfurt, Germany

Anti-Cancer Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in